PET/CT bests biopsy in diagnosing lymphoma bone marrow involvement

05/17/2013 | MolecularImaging.net

A study published in The Journal of Nuclear Medicine said 18F-FDG-PET/CT is better than the standard bone marrow biopsy in detecting bone marrow involvement in diffuse large B-cell lymphoma. PET/CT identified bone marrow involvement in 32 patients, while biopsy detected bone malignancy in eight patients. PET/CT also showed better performance in terms of sensitivity, predictive value and negative predictive value.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA